What You Need to Know About Using Medical Marijuana for Facial Pain
By Jeffrey Fogel, MD, Member of the FPA Board of Directors Dr. Jeffrey Fogel is an FPA Board Member and pediatrician who was diagnosed with trigeminal neuralgia (TN) in 2008
Brandi Underwood Represents the Facial Pain Association at Headache on the Hill
Brandi Underwood, Manager of Development, Research, and Advocacy, represented the Facial Pain Association at the 17th Annual Headache on the Hill by the Alliance for Headache Disorders Advocacy (AHDA) onFacial Pain Association Joins Alliance for Connected Care in Urging Congress to Permanently Extend Telehealth Access
February 29, 2024 The Facial Pain Association (FPA) has co-signed a letter from the Alliance for Connected Care, urging Congress to extend telehealth access permanently. The FPA is committed toRapid-Acting, As-Needed Medications for Trigeminally-Mediated Pain
Dr. Wolfgang Liedtke is an Executive with Regeneron Pharmaceuticals (Tarrytown, NY) in Genetic Medicines in their Global Clinical Development Unit, and member of their Scientific Council where he is Chair of Neurology,
National Institute of Dental and Craniofacial Research Awards Research Grant for Trigeminal Neuralgia
Juan M. Hincapie-Castillo, PharmD, MS, PhD, an Assistant Professor of Epidemiology at the Gillings School of Global Public Health at the University of North Carolina Chapel Hill, received a 5-year
